185 related articles for article (PubMed ID: 11423835)
1. Colletotrichum species as emerging opportunistic fungal pathogens: a report of 3 cases of phaeohyphomycosis and review.
O'Quinn RP; Hoffmann JL; Boyd AS
J Am Acad Dermatol; 2001 Jul; 45(1):56-61. PubMed ID: 11423835
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
3. [Phaeohyphomycosis caused by Colletotrichum gloeosporioides and Alternaría infectoria in renal transplant recipient].
Ogawa M; Reis V; Godoy P; Gatti de Menezes F; Enokihara M; Tomimori J
Rev Chilena Infectol; 2014 Aug; 31(4):468-72. PubMed ID: 25327202
[TBL] [Abstract][Full Text] [Related]
4. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
[TBL] [Abstract][Full Text] [Related]
5. Phaeohyphomycosis in a tertiary care cancer center.
Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
[TBL] [Abstract][Full Text] [Related]
6. Three cases of cutaneous phaeohyphomycosis by Exophiala jeanselmei.
Martínez-González MC; Verea MM; Velasco D; Sacristán F; Del Pozo J; García-Silva J; Fonseca E
Eur J Dermatol; 2008; 18(3):313-6. PubMed ID: 18474462
[TBL] [Abstract][Full Text] [Related]
7. A case report of phaeohyphomycosis caused by Cladophialophora bantiana treated in a burn unit.
Arnoldo BD; Purdue GF; Tchorz K; Hunt JL
J Burn Care Rehabil; 2005; 26(3):285-7. PubMed ID: 15879753
[TBL] [Abstract][Full Text] [Related]
8. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection.
Pagano L; Fianchi L; Caramatti C; D'Antonio D; Melillo L; Caira M; Masini L; Todeschini G; Girmenia C; Martino B; Cinieri S; Martino P; Del Favero A;
Haematologica; 2004 Jul; 89(7):852-6. PubMed ID: 15257938
[TBL] [Abstract][Full Text] [Related]
10. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke M; Maschmeyer G
Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
[TBL] [Abstract][Full Text] [Related]
11. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous phaeohyphomycosis (mycotic cyst).
Isa-Isa R; García C; Isa M; Arenas R
Clin Dermatol; 2012; 30(4):425-31. PubMed ID: 22682192
[TBL] [Abstract][Full Text] [Related]
13. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
Bow EJ
Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
[TBL] [Abstract][Full Text] [Related]
14. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review.
Kumashi PR; Safdar A; Chamilos G; Chemaly RF; Raad II; Kontoyiannis DP
Clin Microbiol Infect; 2006 Jul; 12(7):621-6. PubMed ID: 16774557
[TBL] [Abstract][Full Text] [Related]
15. Treatment of subcutaneous phaeohyphomycosis and prospective follow-up of 17 kidney transplant recipients.
Ogawa MM; Galante NZ; Godoy P; Fischman-Gompertz O; Martelli F; Colombo AL; Tomimori J; Medina-Pestana JO
J Am Acad Dermatol; 2009 Dec; 61(6):977-85. PubMed ID: 19815309
[TBL] [Abstract][Full Text] [Related]
16. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
18. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system phaeohyphomycosis: a review of 101 cases.
Revankar SG; Sutton DA; Rinaldi MG
Clin Infect Dis; 2004 Jan; 38(2):206-16. PubMed ID: 14699452
[TBL] [Abstract][Full Text] [Related]
20. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
Leather HL; Wingard JR
Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
